Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corrigendum to 'Response to letter to the editor (JOTNS-D-25-02717 by Dr. Nie Lei)' [The Journal of the Neurological Sciences 2025 Volume 479 123752].

Journal of the neurological sciences·2025

Same author

Response to letter to the editor (JOTNS-D-25-02717 by Dr. Nie Lei).

Journal of the neurological sciences·2025

Same author

Reported patient safety incidents in radiology - understanding the relation between risk areas and their underlying factors.

Radiography (London, England : 1995)·2025

Same author

Serum neurofilament light chain levels are associated with cognitive decline in a consecutive cohort of patients with Alzheimer's disease.

Journal of the neurological sciences·2025

Same author

Radiographers' perspective of patient safety at ultrasound units in radiology departments.

Radiography (London, England : 1995)·2024

Same author

Serum Tau-A and Tau-C Levels and Their Association with Cognitive Impairment and Dementia Progression in a Memory Clinic Derived Cohort.

The journal of prevention of Alzheimer's disease·2024

Search research articles

Related Experiment Video

Updated: Jul 16, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Absolute Quantification of Aβ_1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods.

A H Simonsen¹, S F Hansson, U Ruetschi

¹Biomarker Discovery Center Facility, Ciphergen, Copenhagen, Denmark. asimonsen@ciphergen.com

Dementia and Geriatric Cognitive Disorders

|February 21, 2007

Summary

Quantifying amyloid beta (Abeta) in cerebrospinal fluid (CSF) using direct protein binding arrays (IMAC30) detected elevated Abeta40 levels in Alzheimer's disease (AD). Antibody-based methods did not yield significant differences, suggesting interference.

More Related Videos

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

Related Experiment Videos

Last Updated: Jul 16, 2026

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Absolute Quantification of Aβ_1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

Published on: March 21, 2017

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

Area of Science:

Neuroscience
Biochemistry
Analytical Chemistry

Background:

Amyloid beta (Abeta) is a key component of senile plaques in Alzheimer's disease (AD).
Soluble Abeta oligomers are increasingly implicated in AD pathogenesis.

Purpose of the Study:

To compare three methods for quantifying Abeta40 in CSF.
To evaluate the impact of different quantification strategies on AD biomarker detection.

Main Methods:

Compared ELISA, antibody-based SELDI-TOF, and direct binding SELDI-TOF (IMAC30) for Abeta40 quantification.
Analyzed cerebrospinal fluid (CSF) samples.

Main Results:

Only SELDI-TOF with IMAC30 arrays showed significantly elevated CSF Abeta40 in AD patients (127% of controls).
Antibody-based methods did not detect significant differences in Abeta40 levels between AD patients and controls.

Conclusions:

CSF Abeta40 measurement is method-dependent.
Antibody-based detection may be affected by Abeta oligomerization or binding to carrier proteins, potentially masking epitopes.